Key result
A multifaceted therapeutic approach is advocated for patients with type 2 diabetes and nephropathy to slow renal dysfunction progression and reduce cardiovascular disease risk.
A multifaceted approach is advocated to slow renal dysfunction progression and reduce cardiovascular disease risk in patients with type 2 diabetes and nephropathy.
May support multifaceted care in T2D nephropathy; leaves open optimal component prioritization in trials.
SUMMARY: Diabetic nephropathy is currently the commonest cause of end‐stage renal failure in most countries with a Western lifestyle. In addition to progressing to end‐stage renal disease, patients with type 2 diabetes and nephropathy are at especially high risk of cardiovascular death. A multifaceted approach, aiming not only to slow the progression of renal dysfunction but also to reduce the risk of associated complications, particularly cardiovascular disease, is advocated. Current evidence‐based guidelines serve a useful adjunctive role in providing target levels for therapeutic intervention.
No takes yet. Share an insight, caveat, or question.
Gilbert et al. (2001) conducted a review in Diabetic nephropathy in type 2 diabetes. Multifaceted therapeutic approach was evaluated. A multifaceted therapeutic approach is advocated for patients with type 2 diabetes and nephropathy to slow renal dysfunction progression and reduce cardiovascular disease risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: